LAS VEGAS, NV--(Marketwired - Dec 21, 2016) - Digipath, Inc. (OTCQB: DIGP), an independent cannabis lab testing and media firm, is pleased to announce that Todd Denkin, President and COO of Digipath, and Cindy Orser, Ph.D., Chief Science Officer of Digipath, were interviewed as part of a recent issue of The Wall Street Transcript (TWST).

TWST publishes interviews of CEOs and senior executives of public companies, money managers, and equity analysts from investment banks around the world. It operates an online searchable database of interviews in the areas of technology, healthcare, natural resources, industry services, consumer goods, financial services, and general investing.

In this interview (pages 16 through 19 of the issue), Mr. Denkin and Dr. Orser speak on various topics, including but not limited to:

  • The background of Digipath and its current business operations;
  • The market opportunity in cannabis laboratory testing;
  • Digipath's competitive landscape;
  • The various strategic partnerships that Digipath is pursuing;
  • The rigorous standards to which Digipath holds itself;
  • Digipath's R&D efforts with regard to standard operating procedures (SOPs) and other processes; and
  • Various trends in the testing protocols for cannabis.

To read this interview, please click on the link below:
Interview Transcript

About Digipath, Inc.

Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath's two business units are Digipath Labs and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, that delivers news, interviews, and education on all things cannabis.

For more information please visit

Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, governmental regulation of the cannabis industry, the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

About Viridian Capital Advisors, LLC

Viridian Capital Advisors, LLC is a financial and strategic advisory firm dedicated to the cannabis industry. Its banking practice, through broker-dealer Pickwick Capital Partners, provides capital to fund the growth of Viridian's clients, while Viridian's advisory practice helps to position and build their businesses. Leveraging its team's decades of high level operating and transactional experience on Wall Street, in industry and in the government, Viridian provides flexible comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

For more information, please visit

Contact Information:

Harrison Phillips
Viridian Capital Advisors, LLC
(212) 485-0284